From a biological perspective, immunohistochemical markers such as Ki-67 and human epithelial growth factor receptor 2 (HER2) and circulating tumour nucleosomes have been suggested to be predictive of the likelihood of breast tumour response to NAC prior to treatment2, 3, 4, 5. Here, MKI67 is linked to breast neoplasm.